Tumour-on-a-Chip Systems to Advance Targeted LNP Delivery for mRNA Therapeutics
- Explore how tumour-on-a-chip platforms provide physiologically relevant models to test LNP targeting and efficacy
- Review case studies demonstrating improved predictability of delivery outcomes compared to conventional in vitro assays
- Understand how these systems accelerate candidate optimization and reduce translational risks in oncology applications